{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:25:33Z","timestamp":1784773533820,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.113067","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:06:32Z","timestamp":1651709192000},"page":"113067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Glycolysis aggravates methotrexate toxicity by fueling RFC1-controlled intestinal absorption in rheumatic rats"],"prefix":"10.1016","volume":"150","author":[{"given":"Qi-Hai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opeyemi Joshua","family":"Olatunji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingcheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113067_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.acvd.2010.03.007","article-title":"High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis","volume":"103","author":"Meune","year":"2010","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2022.113067_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5114\/reum.2014.41452","article-title":"Carbohydrate metabolism disorders in patients with rheumatoid arthritis and ankylosing spondylitis-Impact of the severity of the inflammatory process and disease activity","volume":"1","author":"Dbrowski","year":"2014","journal-title":"Reumatologia"},{"key":"10.1016\/j.biopha.2022.113067_bib3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1136\/annrheumdis-2014-205741","article-title":"The impact of obesity on the development and progression of rheumatoid arthritis","volume":"73","author":"Finckh","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2022.113067_bib4","first-page":"1487","article-title":"Biological therapy in rheumatoid arthritis based on ten years of registry surveillance in Finland","volume":"126","author":"Virkki","year":"2010","journal-title":"Duodecim"},{"key":"10.1016\/j.biopha.2022.113067_bib5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3899\/jrheum.121387","article-title":"Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice","volume":"40","author":"Linde","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113067_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/039463200902200434","article-title":"The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNF alpha treatment in Italian patients","volume":"22","author":"Benucci","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113067_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2022.113067_bib8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2022.113067_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2133\/dmpk.DMPK-13-RV-119","article-title":"Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy","volume":"29","author":"Inoue","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.biopha.2022.113067_bib10","first-page":"645","article-title":"Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis","volume":"31","author":"Hoekstra","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113067_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1586\/ecp.11.57","article-title":"Pharmacokinetic drug-drug interactions with methotrexate in oncology","volume":"4","author":"Lev\u00eaque","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113067_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/rheumatology\/36.1.86","article-title":"Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis","volume":"36","author":"Hamilton","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113067_bib13","first-page":"833","article-title":"Methotrexate: bioavailability and pharmacokinetics","volume":"69","author":"Campbell","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.biopha.2022.113067_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/17425255.2021.1843634","article-title":"Xanthones from Securidaca inappendiculata antagonized the antirheumatic effects of methotrexate in vivo by promoting its secretion into urine","volume":"17","author":"Wang","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2022.113067_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.692806","article-title":"\u03b1-Mangostin alleviated in\ufb02ammation in rats with adjuvant-induced arthritis by disrupting adipocytes-mediated metabolism-immune feedback","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113067_bib16","first-page":"131","article-title":"Shikonin affects uterine leiomyoma in rats by regulating ERK signaling pathway","volume":"27","author":"Wang","year":"2021","journal-title":"Chin. J. Exp. Tradit. Med. Formula"},{"key":"10.1016\/j.biopha.2022.113067_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1211\/jpp.61.07.0010","article-title":"Site-specific contribution of proton-coupled folate transporter\/haem carrier protein 1 in the intestinal absorption of methotrexate in rats","volume":"61","author":"Yokooji","year":"2009","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2022.113067_bib18","article-title":"metabolism rate and relationship with disease activity in patients with rheumatoid arthritis","volume":"27","author":"Okuroglu","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113067_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09674845.2003.11783687","article-title":"Reduced folate carrier: Biochemistry and molecular biology of the normal and methotrexate-resistant cell","volume":"60","author":"Bosson","year":"2003","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2022.113067_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.febslet.2004.04.010","article-title":"The H+-dependent reduced folate carrier 1 of humans and the sodium-dependent methotrexate carrier-1 of the rat are orthologs","volume":"566","author":"Kneuer","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2022.113067_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.113067_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coi.2017.04.010","article-title":"Metabolic signatures of T-cells and macrophages in rheumatoid arthritis","volume":"46","author":"Weyand","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2022.113067_bib23","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2217\/pgs-2016-0067","article-title":"Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome","volume":"17","author":"Lima","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.biopha.2022.113067_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopha.2006.09.007","article-title":"The use of low dose methotrexate in rheumatoid arthritis-are we entering a new era of therapeutic drug monitoring and pharmacogenomics?","volume":"60","author":"Stamp","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113067_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40780-016-0047-6","article-title":"Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis","volume":"2","author":"Hashiguchi","year":"2016","journal-title":"J. Pharm. Health Care Sci."},{"key":"10.1016\/j.biopha.2022.113067_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tips.2012.03.001","article-title":"Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications","volume":"33","author":"Tornio","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2022.113067_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40256-013-0029-0","article-title":"Drug-drug interaction studies of cardiovascular drugs involving p-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor xa inhibitor","volume":"13","author":"Mendell","year":"2013","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.biopha.2022.113067_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2174\/1389200216666150812124359","article-title":"Interactions between transporters and herbal medicines\/drugs: a focus on hepatoprotective compounds","volume":"16","author":"Zhang","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2022.113067_bib29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3389\/fphar.2018.01472","article-title":"Integrating network pharmacology and metabolomics study on anti-rheumatic mechanisms and antagonistic effects against methotrexate-induced toxicity of Qing-Luo-Yin","volume":"9","author":"Zuo","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:38:15Z","timestamp":1780486695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222004565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S0753332222004565"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113067","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycolysis aggravates methotrexate toxicity by fueling RFC1-controlled intestinal absorption in rheumatic rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113067"}}